RSS   Newsletter   Contact   Advertise with us
Post Online Media

ARIAD Pharma appoints Jennifer L. Herron as EVP

ARIAD PharmaceuticalsARIAD Pharmaceuticals, an oncology company, announced the appointment of Jennifer L. Herron as executive vice president and chief commercial officer, effective May 31, 2016.

Ms. Herron comes to ARIAD after a ten-year career at Bristol-Myers Squibb Company (BMS), where she recently accepted the position of Lead, Commercial Transformation and Operating Model.

Article continues below

READ MORE ARIAD Pharmaceuticals: Timothy P. Clackson president of R&D

Previously, Ms. Herron served in various roles of increasing responsibility at BMS, including as Vice President, US Immunology from 2014-2016; and as General Manager for BMS in Puerto Rico and the Caribbean from 2012-2014.

She also served as Executive Director, U.S. Commercial Operations, for BMS from 2010-2012, following several commercial leadership roles in oncology from 2006 through 2009.

Prior to joining BMS, Ms. Herron served in critical marketing roles for in-line and launch assets in oncology for both Novartis and GSK/SmithKline Beecham. She started her pharmaceutical career as a clinical research associate at Boehringer Mannheim Pharmaceuticals.

Ms. Herron earned a Bachelor of Arts in Biology and Economics from Lehigh University and her MBA from Georgetown University.


 LATEST MOVES FROM Massachusetts 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy